|Weekly News Digest
April 16, 2001 — In addition to this week's NewsBreaks article and the monthly NewsLink Spotlight, Information Today, Inc. (ITI) offers Weekly News Digests that feature recent product news and company announcements. Watch for additional coverage to appear in the next print issue of Information Today. For other up-to-the-minute news, check out ITI’s Twitter account: @ITINewsBreaks.
CLICK HERE to view more Weekly News Digest items.
Spotfire Expands DecisionSite Product Family
Spotfire, Inc. (http://www.spotfire.com) has expanded its Spotfire DecisionSite family of eAnalytic applications with the launch of Spotfire DecisionSite for Lead Discovery, its first role-based application for product development. Reportedly the first integrated Web-based application of its kind, Spotfire DecisionSite for Lead Discovery is designed to capitalize on the substantial market opportunity presented by the biotechnology and pharmaceuticals industries.
Spotfire DecisionSite for Lead Discovery specifically addresses the needs of people involved in new-product development within life sciences organizations, and allows researchers and scientists to make potentially breakthrough discoveries. This expansion of the Spotfire DecisionSite product line underscores Spotfire's commitment to provide decision makers in various roles with powerful analytic applications that support effective decision making.
Spotfire DecisionSite for Lead Discovery builds on the functionality of the Spotfire DecisionSite application, which launched in early February. Spotfire DecisionSite is a highly configurable eAnalytic application for end-users that offers interactive visualization, a powerful user interface, and ease to the access, exploration, and analysis of large, disparate data sets.
Spotfire has announced that Biogen, Inc. (http://www.biogen.com), a biopharmaceutical company, has adopted Spotfire DecisionSite to accelerate the drug discovery and development process.
Spotfire has also announced an agreement with Celera Genomics (http://www.celera.com). Under this agreement, the two firms will integrate Spotfire DecisionSite with the Celera Discovery System (CDS), an aggregation of Celera's genomic data—including the human, mouse, and fly genomes—and a variety of other biological and medical databases. This product integration is expected to help life science researchers advance the discovery and analysis processes associated with biological research and new drug development.
Source: Spotfire, Inc.
Send correspondence concerning the Weekly News Digest to NewsBreaks Editor